Literature DB >> 17268901

The effect of ABO-Rh blood group determinants on urinary tract infections.

Onur Sakallioglu1, A Ebru Sakallioglu.   

Abstract

BACKGROUND: Blood group antigens are a group of carbohydrate determinants found on erythrocytes, phagocytes, lymphocytes and certain epithelial tissues including urothelium. There are several publications that defines enhanced bacterial adhesions due to genetic markers such as blood group types.
METHODS: The ABO-Rh blood group distribution of patients with UTI and Escherichia coli(+) urine culture were compared with ABO-Rh blood group distribution of our country.
RESULTS: The distribution of blood groups was as follows; 36.6% A Rh+, 4.9% A Rh-, 12.2% B Rh+, 2.4% B Rh-, 31.7% O Rh+, 2.4% O Rh-, 4.9% AB Rh+, respectively; and none with AB Rh- blood group. There was a significant correlation between our study group and ABO-Rh phenotypes distribution of Turkish population.
CONCLUSIONS: The concordance of UTI with blood group ARh+ may be due to the most seen of ARh+ phenotype in the investigated population. We suggest that before defining the relationships on genetical markers, it would be more reliable to correlate them with their local distributions in the population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17268901     DOI: 10.1007/s11255-006-0075-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status.

Authors:  C Cordon-Cardo; K O Lloyd; C L Finstad; M E McGroarty; V E Reuter; N H Bander; L J Old; M R Melamed
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

2.  Schistosomiasis infection in relation to the ABO blood groups among school children in Zimbabwe.

Authors:  J Ndamba; E Gomo; N Nyazema; N Makaza; K C Kaondera
Journal:  Acta Trop       Date:  1997-05-30       Impact factor: 3.112

3.  P1 blood group and urinary tract infection.

Authors:  H Lomberg; U Jodal; C S Eden; H Leffler; B Samuelsson
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

4.  P blood group and proneness to urinary tract infection in Japanese children.

Authors:  S Tomisawa; T Kogure; T Kuroume; H Leffler; H Lomberg; N Shimabukoro; K Terao; C Svanborg Edén
Journal:  Scand J Infect Dis       Date:  1989

5.  Genetic markers and acute febrile urinary tract infection in the 1st year of life.

Authors:  M H Albarus; F M Salzano; N P Goldraich
Journal:  Pediatr Nephrol       Date:  1997-12       Impact factor: 3.714

6.  Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status.

Authors:  A Stapleton; E Nudelman; H Clausen; S Hakomori; W E Stamm
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women.

Authors:  J Sheinfeld; A J Schaeffer; C Cordon-Cardo; A Rogatko; W R Fair
Journal:  N Engl J Med       Date:  1989-03-23       Impact factor: 91.245

Review 8.  The role of ABO blood groups and secretor status in host defences.

Authors:  C C Blackwell
Journal:  FEMS Microbiol Immunol       Date:  1989-06

9.  Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis.

Authors:  H Lomberg; L A Hanson; B Jacobsson; U Jodal; H Leffler; C S Edén
Journal:  N Engl J Med       Date:  1983-05-19       Impact factor: 91.245

10.  The role of ABO blood groups in infections induced by Staphylococcus saprophyticus and Pseudomonas aeruginosa.

Authors:  J Geisel; M K Steuer; H L Ko; J Beuth
Journal:  Zentralbl Bakteriol       Date:  1995-10
View more
  1 in total

1.  Infections in intensive care unit adult patients harboring multidrug-resistant Pseudomonas aeruginosa: implications for prevention and therapy.

Authors:  B Borgatta; L Lagunes; A T Imbiscuso; M N Larrosa; M Lujàn; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-16       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.